We are a Swiss law firm, dedicated to providing legal solutions to business, tax and regulatory matters.
SWISS LAW AND TAX
Services
Intellectual Property
Life Sciences, Pharma, Biotech
Litigation and Arbitration
Meet our team
Our knowledge, expertise & publications
View all
Events
Deals & Cases
In the VISCHER Innovation Lab, we not only work in the field of law, we also develop our solutions ourselves as far as possible from a technical point of view.
VISCHER Legal Innovation Lab
Red Dragon
Careers
Categories: Employment Law, Corporate and commercial, Life Sciences, Pharma, Biotech, Mergers & Acquisitions, Startup Desk, Tax, Deals & Cases
FoRx Therapeutics AG, a Basel-based biotechnology company developing a new generation of cancer drugs focusing on novel DNA Replication Stress (DRS) pathways activated in cancer, completes a EUR 10M seed-financing round led by M Ventures (venture capital arm of Merck), Novartis Venture Fund and Omega Funds. Pfizer Ventures, the venture capital arm of Pfizer Inc. (NYSE: PFE) and LSP (Life Sciences Partners) also joined the seed-financing.
VISCHER advises FoRx Therapeutics AG on all Swiss legal issues related to the transaction. The VISCHER team includes Christian Wyss (Partner, Life Sciences), Dania Salvisberg-Schneider (Associate, Corporate / M&A), Luzius Zumstein (Associate, Corporate / M&A), Fiona Gao (Associate, Life Sciences), Beatrice Leistner (Associate, Tax), and Gian Geel (Associate, Employment).
Press release FoRx Therapeutics AG
Attorney at Law
ImmunOs Therapeutics AG, in Schlieren, a biopharmaceutical company developing first-in-class...
Developing a product or service and scaling a startup's business model need big amounts of cash....
HAYA Therapeutics SA, a Swiss biotechnology company pioneering precision RNA-guided regulatory...
